Investigation summary: with the available information boston scientific has concluded that the reported patient symptom is a known risk associated with spectra penile prosthesis procedures and is noted as such in the device instructions for use (ifu).Device analysis did not find any product issues.Device history record (dhr) review: dhr review confirmed that the device met all material, assembly and performance specifications.Device technical analysis: upon receipt at our post market quality assurance laboratory, this device was thoroughly analyzed.Visual examination found sharp instrument/tool damage to the outer tube in the distal cylinder bodies of both cylinders.Holes and exposed metal segments resulted from this damage, which is consistent with that sustained during explant.Both cylinders were functionally tested and passed testing, performing within specification.Product analysis did not find any device issue.Labeling review: a review of the device ifu was completed and did not reveal any evidence of device misuse, off label use, or failure to follow instructions.Additionally, the patient symptom of inflammation was found to be listed in the ifu.Investigation conclusion: based on the information available, a conclusion code of known inherit risk of device was assigned to this investigation.
|